» Articles » PMID: 28507467

Preparation and Characterization of Beta-glucan Particles Containing a Payload of Nanoembedded Rifabutin for Enhanced Targeted Delivery to Macrophages

Overview
Journal EXCLI J
Specialty Biology
Date 2017 May 17
PMID 28507467
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

β-glucan particles (GP) are polymeric carbohydrates, mainly found as components of cell wall fungi, yeast, bacteria and also in cereals such as barley and oat, and have been recently shown to have application in macrophage-targeted drug delivery. The aim of this study was to prepare and characterize GP containing a large payload of Rifabutin (RB), an anti-tuberculosis drug effective against MDR-TB at lower MIC than Rifampicin. GP were prepared from yeast cells by acidic and alkaline extraction were either spray dried or lyophilized, prior to RB loading and alginate sealing. The FTIR and C-NMR spectra of the GP confirmed a β-(1→3) linked glucan structure, with a triple-helical conformation. The spray dried GP exhibited better characteristics in terms of uniformity, size range (2.9 to 6.1 µm) and more than 75 % particles were below 3.5 μm. The RP-HPLC analysis of spray dried GP revealed drug entrapment and drug loading up to 81.46 ± 4.9 % and ~40.5 ± 1.9 %, respectively, as compared to those dried by lyophilization. Electron microscopy showed nearly spherical and porous nature of GP, and the presence of drug 'nanoprecipitates' filling the pore spaces. The formulation showed adequate thermal stability for pharmaceutical application. The particles were readily phagocytosed by macrophage(s) within 5 min of exposure. Drug release occurred in a sustained manner via diffusion, as the release kinetics best fit for drug release was obtained using Higuchi's equation. Thus, the spray dried GP-based-formulation technology holds promise for enhanced targeted delivery of anti-TB drug(s) to macrophage within a therapeutic window for the clearance of intracellular bacteria

Citing Articles

Synthesis of immunomodulatory biomimetic lipid polymer hybrid nanoparticles and application of zebrafish larvae in immunomodulation screening.

Irabin A, Ollewagen T, Smith C, Ahmed R, Reineke J, Reijnders R Eur J Pharm Sci. 2025; 207:107037.

PMID: 39933629 PMC: 11890185. DOI: 10.1016/j.ejps.2025.107037.


Targeted delivery of antitubercular drugs using glucan lipid particles.

Jaecklein E, Papavinasasundaram K, Ostroff G, Sassetti C, Soto E Microbiol Spectr. 2025; 13(3):e0274424.

PMID: 39912634 PMC: 11878006. DOI: 10.1128/spectrum.02744-24.


Progress and prospect of polysaccharides as adjuvants in vaccine development.

Liang X, Zhou J, Wang M, Wang J, Song H, Xu Y Virulence. 2024; 15(1):2435373.

PMID: 39601191 PMC: 11622597. DOI: 10.1080/21505594.2024.2435373.


Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy.

Liu Y, Wang J, Yang J, Xia J, Yu J, Chen D J Nanobiotechnology. 2024; 22(1):608.

PMID: 39379986 PMC: 11462893. DOI: 10.1186/s12951-024-02875-w.


Unlocking the potential of beta-glucans: a comprehensive review from synthesis to drug delivery carrier potency.

Eluppai Asthagiri Kumaraswamy N, Jayaramamurthy S, Ann Martin C, Srinivasan B Drug Deliv Transl Res. 2024; 15(2):483-507.

PMID: 39120791 DOI: 10.1007/s13346-024-01694-8.


References
1.
Marzolini C, Chave J, Telenti A, Biollaz J . Impaired absorption of rifabutin by concomitant administration of didanosine. AIDS. 2001; 15(16):2203-4. DOI: 10.1097/00002030-200111090-00022. View

2.
Etzerodt A, Maniecki M, Graversen J, Moller H, Torchilin V, Moestrup S . Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. J Control Release. 2012; 160(1):72-80. DOI: 10.1016/j.jconrel.2012.01.034. View

3.
Zhu S, Niu M, OMary H, Cui Z . Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol Pharm. 2013; 10(9):3525-30. PMC: 3946577. DOI: 10.1021/mp400216r. View

4.
Muttil P, Kaur J, Kumar K, Yadav A, Sharma R, Misra A . Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci. 2007; 32(2):140-50. DOI: 10.1016/j.ejps.2007.06.006. View

5.
Sharma R, Saxena D, Dwivedi A, Misra A . Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm Res. 2001; 18(10):1405-10. DOI: 10.1023/a:1012296604685. View